{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:24:36Z","timestamp":1787012676533,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the 2021 overseas training grant from Pusan National University Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Postoperative macular edema is a recognized complication following vitrectomy for idiopathic epiretinal membrane (ERM), particularly after combined phacovitrectomy. Topical nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit prostaglandin-mediated disruption of the blood-retinal barrier, but their long-term anatomical impact after ERM surgery has not been established. We retrospectively reviewed 282 eyes from 279 patients who underwent vitrectomy or phacovitrectomy for idiopathic ERM. Patients were categorized into an Early Use Group (topical bromfenac initiated within 4\u00a0weeks postoperatively, n\u2009=\u200991) and a Late\/No Use Group (n\u2009=\u2009191). The primary outcome was the change in central subfield macular thickness (CSMT) measured by OCT over 6\u00a0months. Longitudinal analysis was performed using a linear mixed-effects model (LME) with treatment-by-time interaction as the primary term. LME analysis revealed a significant treatment-by-time interaction for CSMT in the full cohort (F\u2009=\u20094.62,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.003) and in the phacovitrectomy subgroup (F\u2009=\u20096.23,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). The Early Use Group showed a significantly greater reduction in CSMT at 6\u00a0months (93.9\u2009\u00b1\u200956.2\u00a0\u03bcm) compared with the Late\/No Use Group (76.6\u2009\u00b1\u200952.8\u00a0\u03bcm), with an estimated marginal mean difference of approximately 14\u201315\u00a0\u03bcm maintained at all post-baseline time points (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009\u2264\u20090.006). For logMAR BCVA, a significant treatment-by-time interaction was also observed (F\u2009=\u20092.68,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.046): the Early Use Group showed significantly faster visual recovery at 1\u00a0month (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.016), but both groups converged to equivalent visual acuity by 6\u00a0months (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.305). Early postoperative bromfenac within 4\u00a0weeks of phacovitrectomy for ERM significantly reduces macular thickness, and this anatomical benefit is durably maintained for at least 6\u00a0months, along with accelerated visual acuity recovery at 1\u00a0month. These findings raise the hypothesis that prostaglandin-mediated vascular permeability in the early postoperative period may influence long-term macular remodeling; however, this remains speculative, as direct evidence of permeability changes was not assessed in this study.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-50272-0","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:03:47Z","timestamp":1780704227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term effects of short-term postoperative bromfenac on macular thickness after phacovitrectomy for idiopathic epiretinal membrane"],"prefix":"10.1038","volume":"16","author":[{"given":"No Hae","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Hyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ik Soo","family":"Byon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungwho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"key":"50272_CR1","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1136\/bjophthalmol-2017-311188","volume":"102","author":"YJ Kim","year":"2018","unstructured":"Kim, Y. J. et al. Macular capillary plexuses after epiretinal membrane surgery: an optical coherence tomography angiography study. Br J Ophthalmol. 102, 1086\u20131091. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311188 (2018).","journal-title":"Br J Ophthalmol."},{"key":"50272_CR2","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0161-6420(89)32811-9","volume":"96","author":"WE Smiddy","year":"1989","unstructured":"Smiddy, W. E. et al. Idiopathic Epiretinal Membranes. Ophthalmology 96, 811\u2013821. https:\/\/doi.org\/10.1016\/S0161-6420(89)32811-9 (1989).","journal-title":"Ophthalmology"},{"key":"50272_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41433-021-01681-0","volume":"36","author":"PY Chua","year":"2022","unstructured":"Chua, P. Y., Sandinha, M. T. & Steel, D. H. Idiopathic epiretinal membrane: progression and timing of surgery. Eye 36, 495\u2013503. https:\/\/doi.org\/10.1038\/s41433-021-01681-0 (2022).","journal-title":"Eye"},{"key":"50272_CR4","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s00417-007-0579-4","volume":"245","author":"J Michalewski","year":"2007","unstructured":"Michalewski, J., Michalewska, Z., Cisiecki, S. & Nawrocki, J. Morphologically functional correlations of macular pathology connected with epiretinal membrane formation in spectral optical coherence tomography (SOCT). Graefes Arch. Clin. Exp. Ophthalmol. 245, 1623\u20131631. https:\/\/doi.org\/10.1007\/s00417-007-0579-4 (2007).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"50272_CR5","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.3341\/jkos.2011.52.11.1302","volume":"52","author":"P Lee","year":"2011","unstructured":"Lee, P. et al. Prognostic factors in vitrectomy for macular epiretinal membrane. J. Korean Ophthalmol. Soc. 52, 1302. https:\/\/doi.org\/10.3341\/jkos.2011.52.11.1302 (2011).","journal-title":"J. Korean Ophthalmol. Soc."},{"issue":"6","key":"50272_CR6","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/00006982-199911000-00010","volume":"19","author":"K Kadonosono","year":"1999","unstructured":"Kadonosono, K., Itoh, N., Nomura, E. & Ohno, S. Capillary blood flow velocity in patients with idiopathic epiretinal membranes. Retina 19(6), 536\u2013539. https:\/\/doi.org\/10.1097\/00006982-199911000-00010 (1999).","journal-title":"Retina"},{"key":"50272_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00417-014-2655-x","volume":"253","author":"R Frisina","year":"2015","unstructured":"Frisina, R. et al. Cystoid macular edema after pars plana vitrectomy for idiopathic epiretinal membrane. Graefes Arch. Clin. Exp. Ophthalmol. 253, 47\u201356. https:\/\/doi.org\/10.1007\/s00417-014-2655-x (2015).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"50272_CR8","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00417-014-2841-x","volume":"253","author":"L Pierro","year":"2015","unstructured":"Pierro, L. et al. Role of ganglion cell complex in visual recovery following surgical internal limiting membrane peeling. Graefes Arch. Clin. Exp. Ophthalmol. 253, 437\u2013445. https:\/\/doi.org\/10.1007\/s00417-014-2841-x (2015).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"50272_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00417-014-2762-8","volume":"253","author":"SW Park","year":"2015","unstructured":"Park, S. W., Byon, I. S., Kim, H. Y., Lee, J. E. & Oum, B. S. Analysis of the ganglion cell layer and photoreceptor layer using optical coherence tomography after idiopathic epiretinal membrane surgery. Graefes Arch. Clin. Exp. Ophthalmol. 253, 207\u2013214. https:\/\/doi.org\/10.1007\/s00417-014-2762-8 (2015).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"50272_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.survophthal.2014.08.005","volume":"60","author":"S Guo","year":"2015","unstructured":"Guo, S. et al. Management of pseudophakic cystoid macular edema. Surv. Ophthalmol. 60, 123\u2013137. https:\/\/doi.org\/10.1016\/j.survophthal.2014.08.005 (2015).","journal-title":"Surv. Ophthalmol."},{"key":"50272_CR11","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/IAE.0b013e31821e2057","volume":"32","author":"P Naithani","year":"2012","unstructured":"Naithani, P. et al. Role of topical nepafenac in prevention and treatment of macular edema after vitreoretinal surgery. Retina 32, 250\u2013255. https:\/\/doi.org\/10.1097\/IAE.0b013e31821e2057 (2012).","journal-title":"Retina"},{"key":"50272_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14873","author":"ED Mandelcorn","year":"2022","unstructured":"Mandelcorn, E. D. et al. A prospective randomized clinical trial comparing nepafenac, intravitreal triamcinolone and no adjuvant therapy for epiretinal membrane. Acta Ophthalmol. https:\/\/doi.org\/10.1111\/aos.14873 (2022).","journal-title":"Acta Ophthalmol."},{"key":"50272_CR13","doi-asserted-by":"publisher","first-page":"1482.e1","DOI":"10.1016\/j.ophtha.2011.01.034","volume":"118","author":"SD Schoenberger","year":"2011","unstructured":"Schoenberger, S. D. et al. Nepafenac for epiretinal membrane surgery. Ophthalmology 118, 1482.e1-1482.e3. https:\/\/doi.org\/10.1016\/j.ophtha.2011.01.034 (2011).","journal-title":"Ophthalmology"},{"key":"50272_CR14","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1097\/IAE.0b013e318227ab39","volume":"32","author":"A Almony","year":"2012","unstructured":"Almony, A. et al. Techniques, rationale, and outcomes of internal limiting membrane peeling. Retina 32, 877\u2013891. https:\/\/doi.org\/10.1097\/IAE.0b013e318227ab39 (2012).","journal-title":"Retina"},{"key":"50272_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.21561\/jor.2022.7.1.21","volume":"7","author":"SH Kim","year":"2022","unstructured":"Kim, S. H. et al. Topographical characteristics of the macula after removing the internal limiting membrane. J. Retin. 7, 21\u201326. https:\/\/doi.org\/10.21561\/jor.2022.7.1.21 (2022).","journal-title":"J. Retin."},{"key":"50272_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjo.2023.11.020","author":"SW Park","year":"2023","unstructured":"Park, S. W. et al. Cystoid macular edema after vitrectomy and after phacovitrectomy for epiretinal membrane. Canadian J. Ophthalmol. https:\/\/doi.org\/10.1016\/j.jcjo.2023.11.020 (2023).","journal-title":"Canadian J. Ophthalmol."},{"key":"50272_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ajo.2016.12.006","volume":"175","author":"A Govetto","year":"2017","unstructured":"Govetto, A. et al. Insights into epiretinal membranes: Presence of ectopic inner foveal layers and a new optical coherence tomography staging scheme. Am. J. Ophthalmol. 175, 99\u2013113. https:\/\/doi.org\/10.1016\/j.ajo.2016.12.006 (2017).","journal-title":"Am. J. Ophthalmol."},{"key":"50272_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5301\/EJO.2010.6049","volume":"21","author":"J Cunha-Vaz","year":"2011","unstructured":"Cunha-Vaz, J., Bernardes, R. & Lobo, C. Blood-retinal barrier. Eur. J. Ophthalmol. 21, 3\u20139. https:\/\/doi.org\/10.5301\/EJO.2010.6049 (2011).","journal-title":"Eur. J. Ophthalmol."},{"key":"50272_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2025.01.001","author":"E Sadeghi","year":"2025","unstructured":"Sadeghi, E. et al. Anatomical and functional changes after internal limiting membrane peeling. Surv. Ophthalmol. https:\/\/doi.org\/10.1016\/j.survophthal.2025.01.001 (2025).","journal-title":"Surv. Ophthalmol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50272-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50272-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50272-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:29:41Z","timestamp":1787009381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50272-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["50272"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-50272-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"6 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25791"}}